Gastrointestinal Endoscopy
Volume 68, Issue 5 , Pages 856-858 , November 2008

Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?

References 

  1. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux is a strong risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831
  2. Lagergren J, Ye W, Bergström R, et al. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA. 2000;284:961–962
  3. Berrino F, Gatta G, Chessa E, et al. Introduction: the EUROCARE II Study. Eur J Cancer. 1998;34:2139–2153
  4. Rubenstein JH, Sonnenberg A, Davis J, et al. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc. 2008;68:849–855
  5. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831
  6. Inadomi JM, Sampliner R, Lagergren J, et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med. 2003;138:176–186
  7. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888–1895
  8. Mashimo H, Wagh MS, Goyal RK. Surveillance and screening for Barrett esophagus and adenocarcinoma. J Clin Gastroenterol. 2005;39:33–41
  9. Thomas T, Abrams KR, De Caestecker JS, et al. Meta analysis: cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther. 2007;26:1465–1477
  10. Lim CH, Treanor D, Dixon MF, et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy. 2007;39:581–587
  11. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920
  12. Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg. 2004;91:943–947
  13. Viklund P, Wengström Y, Rouvelas I, et al. Quality of life and persisting symptoms after esophageal cancer surgery. Eur J Cancer. 2006;42:1407–1414
  14. Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6:864–870
  15. Picasso M, Blanchi S, Filiberti R, et al. Mucosectomy for high-grade dysplasia in Barrett's esophagus. Minim Invasive Ther Allied Technol. 2006;15:325–330
  16. Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2007;132:1226–1233
  17. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?. Gut. 2005;54:1–5

PII: S0016-5107(08)01702-1

doi: 10.1016/j.gie.2008.04.020

Gastrointestinal Endoscopy
Volume 68, Issue 5 , Pages 856-858 , November 2008

Article Tools